A study number comes with a story
In the STEP 1 trial, researchers studied semaglutide injections with a target dose of 2.4 mg once weekly, compared with placebo. Participants were adults without diabetes who had obesity, or overweight with a weight-related condition. Both groups had lifestyle support. The study followed weight changes for 68 weeks.
The trial used gradual increases toward that target; it wasn't the starting amount. These findings concern the manufactured injection studied and don't establish equivalent results for a compounded product.
That tells us what the researchers studied. It doesn't give you a starting amount, a target or instructions for changing treatment. Copying the number leaves most of the story behind.
Same ingredient, different product
The Wegovy (semaglutide) label and Ozempic (semaglutide) injection label describe their own uses and treatment schedules. The ingredient name alone doesn't tell you which set of instructions belongs to a product.
A tablet and an injection also can't be swapped by matching the number on the packaging. Milligrams describe an amount of medicine. They don't make different forms interchangeable, or tell you a volume to measure.
Why isn't it just a matter of finding a number?
How someone tolerates treatment matters. A combined analysis of weight-management trials found digestive problems often appeared while the study treatment was being increased. Most were mild to moderate and temporary, but that group pattern can't tell someone what to do about a particular symptom.
The Wegovy label also raises questions about other diabetes medicines, diabetic eye disease and pregnancy plans. Those are part of an individual review. A dose chart can't have that conversation.
Compounded products add a measurement question
Compounded medicines are not FDA-approved. The FDA has received reports of harmful events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide. Its explanation of these risks is a good reason to resolve unclear instructions with the prescribing and dispensing professionals responsible for the medicine.
This page has no conversions or measuring directions. The useful question is who can explain the instructions for the actual product in front of you.
Questions to bring along
- Which exact product and form are we discussing?
- What would follow-up check, including side effects?
- Who can clarify written instructions?
- Who handles a problem between appointments?
The FAQ adds the wider questions about suitability. A useful answer about doses begins with the person and product, rather than the biggest number in a study.